Martin Latterich

Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry

ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA.

Biomatrica, Inc. produces reagents and devices used for sample collection and analysis in diagnostics systems, nucleic acid analysis, and bio banking. Its technology is used to protect analyst in samples at the molecular and cellular level, chemically position laboratory workflows on microfluidics chips. The firm’s products include DNAstable, DNAgard, RNAstable and RNAgard. The company was founded by Judy L. Müller-Cohn and Rolf Müller in 2004 and is headquartered in San Diego, CA.

Histogen, Inc. is a regenerative medicine company. It focuses on developing patented technologies that replace and regenerates tissues in the body. The firm's applications include hair stimulating complex, matrix regeneration, and skin care. The company was founded in 2007 and is headquartered in San Diego, CA.

The Nicholas Conor Institute Corp. is an American company that focuses on researching and developing cancer treatments for adolescents. The private company was founded by Martin Latterich and the CEO is Beth Baber.

Proteogenomics Research Institute for Systems Medicine is a non-profit biomedical research institute that focuses on developing innovative treatments for important human diseases, including cancer and pulmonary fibrosis. The non-profit company is based in San Diego, CA, in the historic village of La Jolla. The institute employs the principles of systems science to study the relationships between healthy and diseased tissue, with the goal of developing more effective and less toxic treatments to improve patient care and address important unmet medical needs. Scientists at the institute have pioneered an integrated proteomic and imaging discovery platform for the identification and validation of tissue-specific delivery targets to enable the rapid and specific penetration of therapeutic agents directly into diseased tissue, including select solid tumors.